Edesa Biotech, Inc. (EDSA) stock
EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
$1.96+0.07 (+3.70%)
Close on Nov 17, 2026Market cap $18.90MP/E –Yield –
Edesa Biotech price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Edesa Biotech's price to book ratio was 2.4× on Nov 11, 2026, against 1.0× a year earlier. Over the last 5 years it ranged from 0.7× to 40.1×, with a median of 3.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.4× | +1.6 |
| 2025 | Dec 31, 2025 | 0.8× | −1.9 |
| 2024 | Dec 31, 2024 | 2.8× | +0.8 |
| 2023 | Dec 29, 2023 | 2.0× | −1.8 |
| 2022 | Dec 30, 2022 | 3.8× | −36.3 |
| 2021 | Dec 31, 2021 | 40.1× | −3.0 |
| 2020 | Dec 31, 2020 | 43.1× | +2.2 |
| 2019 | Dec 31, 2019 | 41.0× | −16.4 |
| 2018 | Dec 31, 2018 | 57.4× | +9.0 |
| 2017 | Dec 29, 2017 | 48.4× | −21.8 |
| 2016 | Dec 30, 2016 | 70.2× | −206.9 |
| 2015 | Dec 31, 2015 | 277.1× | −218.1 |
| 2014 | Dec 31, 2014 | 495.2× | +67.2 |
| 2012 | Nov 30, 2012 | 428.0× | – |
See a number that looks wrong?